2CJ-26740-10033 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-20
Dose 1 — Moderna
2021-01-28
Registered in v-safe
2021-01-28
Health check-in — day 7, dose 1
Feeling: Fair · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Adult check-in
2021-01-28
Report sent to call center — day 7, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-03
Survey response — day 14, dose 1
MedDRA: Rash pruritic, Urticaria — Feeling: Poor · Be unable to do your normal daily activities

Free text: Hives/ Rash continued to spread and very itchy.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-10
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-02-19
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 35, dose 1
Feeling: Good

Adult check-in
2021-02-26
Dose 2 — Moderna
2021-02-26
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-03
Survey response — days 1–6 daily, dose 2
MedDRA: Blood glucose increased, Diabetes mellitus, Increased insulin requirement, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

Free text: High blood sugars requiring almost double the amount of normal insulin

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-04
Survey response — days 1–6 daily, dose 2
MedDRA: Blood glucose increased — Feeling: Fair

Free text: High blood sugar continue to need much larger amounts of insulin than normal

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-05
Survey response — day 7, dose 2
MedDRA: Blood glucose increased — Feeling: Fair

Free text: Higher than normal insulin needs continues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Survey response — day 14, dose 2
MedDRA: Rash pruritic — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Rash over several spots on the body which is very itchy.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Report sent to call center — day 14, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-19
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-03-26
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-04
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-11
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-22
Call 1 — Left Voicemail
2021-08-31
Survey response — 6 months, dose 2
MedDRA: Dry mouth, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Dry mouth which doesnt go away with water and completely dries at times when exercising. · Healthcare visit (other): Waiting on appointment

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-31
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-02
Call 1 — Left Voicemail
2022-03-03
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-20	Moderna
2	2021-02-26	Moderna

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 3 — day 14, dose 1

2021-02-03

Symptoms: Hives/ Rash continued to spread and very itchy.

Release 4 — days 1–6 daily, dose 2

2021-03-03

Systemic reaction (other): High blood sugars requiring almost double the amount of normal insulin

Release 5 — days 1–6 daily, dose 2

2021-03-04

Systemic reaction (other): High blood sugar continue to need much larger amounts of insulin than normal

Release 5 — day 7, dose 2

2021-03-05

Systemic reaction (other): Higher than normal insulin needs continues

Release 5 — day 14, dose 2

2021-03-12

Symptoms: Rash over several spots on the body which is very itchy.

Release 9 — 6 months, dose 2

2021-08-31

Symptoms: Dry mouth which doesnt go away with water and completely dries at times when exercising.

Healthcare visit (other): Waiting on appointment

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	·	✓
SD	Dry mouth	✓	·	✓
SD	Rash pruritic	✓	✓	✓
SD	Urticaria	✓	✓	✓
SRO	Blood glucose increased	✓	✓	✓
SRO	Diabetes mellitus	✓	✓	✓
SRO	Increased insulin requirement	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release